Upload
laval-technopole
View
203
Download
0
Embed Size (px)
DESCRIPTION
The Biotech City is a biopharmaceutical and life sciences cluster in Greater Montreal, located near an international airport and subway network. The life sciences sector in Laval is comprised of more than 90 companies and institutions, many of which are leaders in Canada’s science economy and which employ some 5,000 people within a four-kilometre radius
Citation preview
MONTREAL-TRUDEAU(YUL)
MONTREAL-MIRABELFREIGHT (YMX)
LAVAL
MONTREAL
THEBIOTECH CITYYOUR NORTH AMERICAN GATEWAY TO BIOSUCCESS
Boston1h 15min
Toronto1h 10min
New York1h 25min
San Francisco6h 25min
London6h 45min
Paris6h 50min
jobs
companies
institutes and organizations
in investments from 2001 to 2013
5 000
86
11
More than $3B
A BUSINESS AND SCIENCE CENTRE
PRODUCTION
CLINICAL TRIALS
RENTAL SPACE
INCUBATORPRE-CLINICAL
DEVELOPMENT
DEVELOPMENT
PROPERTIES
RESEARCH
INSTITUTES
DISCOVERY
CENTRE NATIONAL DE BIOLOGIE EXPÉRIMENTALE (CNBE) INRS-INSTITUT ARMAND-FRAPPIER QUEBEC BIOTECHNOLOGY INNOVATION CENTRE (QBIC)
THE BIOTECH CITYALL DEVELOPMENT PHASES: ONE SITE
Montreal (QC)
Boston (MA)
Chicago (IL)
Frankfurt (GER)
London (EN)
San Diego (CA)
San Francisco (CA)
Toronto (ON)
20 40 60 80 100 120
THE QUEBEC ADVANTAGE
Operating costs among the lowest of the G8Given its affordable labour, capital and operatingcosts, Quebec is one of the most attractive locations inthe world for biopharmaceutical development, drugmanufacturing and clinical trials.
PHARMA MANUFACTURING
BIOMEDICAL R&D
CLINICAL TRIALS
Quebec’s generous tax and R&D incentivesThe net cost of a $100 expenditure on R&D can be as low as $50. Thetax credit is refundable during the R&D process.
Foreign researchers and experts may qualify for a five-year provincialincome tax exemption.
At 26.9%, corporate income tax in Quebec is one of the lowest inNorth America.
An innovation-based economyQuebec offers biopharmaceutical corporations a 27.5% tax credit ratefor R&D salaries.
At the heart of the Canadian healthcare industryNearly half of Canada’s healthcare companies and the majority of thecountry’s basic and clinical research activities are concentrated in theMontreal region.
A highly qualified pool of talent• 400 companies and 25,000 employees in life sciences industry
• 10,000 researchers in public biomedical research centres
• 5,000 graduates each year in biopharmaceutical-related programs
Source: Investissement Québec, September 2013
AVER
AGEANNUALOPER
ATINGCOST
S
Cont
ract
Res
earc
hO
rgan
izat
ions
(CR
O)
Phar
mac
eutic
al
Info
rmat
ion
Tech
nolo
gy
Bio
tech
nolo
gy
Res
earc
hCe
ntre
s/O
rgan
izat
ions
Cons
ultin
g/S
ervi
ce/D
istr
ibut
ion
Med
ical
Dev
ices
and
Res
earc
h
Nut
race
utic
alan
dco
smec
eutic
al
9% 7% 12% 11% 20% 19% 5% 17%
THE BIOTECH CITYTHE DIVERSITY OF LIFE SCIENCES
The Biotech City is a biopharmaceutical and life sciences cluster in Greater Montreal, located near an international airport andsubway network. The life sciences sector in Laval is comprised of more than 90 companies and institutions, many of which areleaders in Canada’s science economy and which employ some 5,000 people within a four-kilometre radius. The hub is made upof companies specializing in biotechnology, pharmaceuticals, medical equipment, CROs and information technology. The BiotechCity is also home to an integrated life sciences technology park built around two research institutes, a business incubator, laboratoryfacilities and development lots.
The Biotech City helps drive the life sciences industry• Promotes networking among businesses, investors, research institutes and government agencies• Organizes and participates in biopharmaceutical sector events• Represents the life sciences sector on a local and international level
The Biotech City will support you in your implementation project• Assistance in finding lots, sites and facilities• Guidance and support through all administrative steps• International mobility expertise
1555 Chomedey Blvd., Suite 100Laval, Quebec H7V 3Z1 CANADA
Telephone: 450-978-5066 | Fax: [email protected] | www.citebiotech.com
Partners
A POLE OF